CytoVista
PrivateCompany Overview
CytoVista is a biotechnology company that develops intelligent AI platforms for hematopathology to improve diagnostic workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
hematopathology AIflow cytometry analysisautomated gatingdigital pathologyclinical AIimmunophenotype analysisFCS datapathology workflowmedical imaging AILIS integrationlab automationdiagnostic softwareSaaS healthcarecomputational pathologyAI diagnostics
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoVista Comparables
Compare CytoVista with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AltraBio | 78% | |
| Neomend | 75% | |
| Siemens | 74% | |
CytoVista Funding Rounds
Historical fundraising activity
CytoVista Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CytoVista's valuation, stock price, and market status.
See something wrong or outdated?